Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. | 3,583,548 | reported | 05 Mar 2026 | tx 44+3,281,830−1,033,959 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 248,865 | 0.00 USD | |
| 05 Mar 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 373,295 | 0.00 USD | deriv |
| 02 Mar 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 29,282 | 14.48 USD | |
| 02 Feb 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 15,500 | 14.68 USD | |
| 16 Jan 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 2,818 | 7.57 USD | |
| 16 Jan 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 1,974 | 13.83 USD | |
| 15 Jan 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 197,182 | 7.57 USD | |
| 15 Jan 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 136,193 | 13.59 USD | |
| 15 Jan 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 197,182 | 0.00 USD | deriv |
| 16 Jan 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 2,818 | 0.00 USD | deriv |
| 06 Jan 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 7,715 | 11.09 USD | |
| 30 Sept 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 29,733 | 14.34 USD | |
| 30 Sept 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 200 | 15.00 USD | |
| 31 Mar 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 21,490 | 3.47 USD | |
| 06 Mar 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 180,118 | 0.00 USD | |
| 06 Mar 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 270,177 | 0.00 USD | deriv |
| 03 Mar 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 4,595 | 3.17 USD | |
| 03 Feb 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 11,851 | 3.47 USD | |
| 06 Jan 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 7,471 | 4.05 USD | |
| 30 Sept 2024 | SALE | Amylyx Pharmaceuticals, Inc. | 18,589 | 3.20 USD | |
| 23 Sept 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 1,857 | 1.57 USD | |
| 23 Sept 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 1,857 | 0.00 USD | deriv |
| 12 Sept 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 34,449 | 1.57 USD | |
| 12 Sept 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 34,449 | 0.00 USD | deriv |
| 16 Apr 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 179,850 | 0.00 USD |